A conference which will address schizophrenia, its treatment, drugs and outcomes, will be held at the University of Hertfordshire next week.
The conference, which has been organised by The Bedfordshire & Hertfordshire Postgraduate Medical School and the Hertfordshire Partnership Trust and will be held at the University's Fielder Centre on Wednesday 20 June from 1pm-4.30pm, will consider current issues in the pharmacotherapy of schizophrenia, consider whether substances of abuse are injurious to the brain and mind, and look at how further progress might be made in optimising the outcome for schizophrenia.
In a presentation entitled: Drugs of Abuse: Damage to the Brain and Mind, Professor Fabrizio Schifano, from the University's School of Pharmacy, will present new research findings into the psychopathological disturbances caused by methamphetamines and particularly "crystal meth", which according to the International Narcotics Control Board is "emerging as the world's biggest problem".
Other speakers at the event include Dr Peter Haddad, University of Manchester who will present on Long Acting Injectable Antipsychotic Therapy: An overview and Professor Chris Hawley from the University of Hertfordshire and Hertfordshire Partnership Trust who will deliver a presentation entitled: Schizophrenia Outcomes: Is better possible?
The programme is expected to be of interest to senior psychiatrists, psychiatrists in training and psychiatric nurses.
For further information and to reserve a place, please contact Mrs Janice Darling on 01707 365435, email: Janice.Darling@hpt.nhs.uk.